BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/4/2025 12:11:39 PM | Browse: 6 | Download: 39
 |
Received |
|
2025-01-24 09:08 |
|
Peer-Review Started |
|
2025-01-24 09:08 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2025-04-15 02:55 |
|
Revised |
|
2025-04-17 21:15 |
|
Second Decision |
|
2025-06-03 02:55 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2025-06-03 08:50 |
|
Articles in Press |
|
2025-06-03 08:50 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-07-07 08:59 |
|
Publish the Manuscript Online |
|
2025-08-04 12:11 |
| ISSN |
2222-0682 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Systematic Reviews |
| Article Title |
Safety and efficacy of glucagon-like peptide-1 receptor agonists in individuals with type 2 diabetes mellitus fasting during Ramadan: a systematic review and meta-analysis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Abul Bashar Mohammad Kamrul-Hasan, Joseph M Pappachan, Hamid Ashraf, Lakshmi Nagendra, Deep Dutta, Mohammad Shafi Kuchay and Shehla Shaikh |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Joseph M Pappachan, FRCP, MD, Professor, Senior Researcher, Faculty of Science, Manchester Metropolitan University, All Saints Building, Manchester M156BH, Greater Manchester, United Kingdom. drpappachan@yahoo.co.in |
| Key Words |
Type 2 diabetes mellitus; Glucagon-like peptide-1 receptor agonist; Ramadan; Religious fasting; Safety; Meta-analysis |
| Core Tip |
No systematic review and meta-analysis (MA) have previously assessed the safety and efficacy of glucagon-like peptide-1 receptor agonists (GLP-1RAs) in individuals with type 2 diabetes mellitus who fast during Ramadan. This MA of 4 studies with 754 participants from 11 countries identified that GLP-1RAs are safe with only exaggerated gastrointestinal side effects, mainly nausea and vomiting. GLP-1RA also appears to be effective in improving glycated hemoglobin and helping weight loss compared to other glucose-lowering medications. However, other cardiometabolic benefits like blood pressure and lipid profile improvement were not evident. Larger multinational, randomized trials with wider global participation are necessary for making firmer clinical practice recommendations for using GLP-1RAs during Ramadan fasting. |
| Publish Date |
2025-08-04 12:11 |
| Citation |
<p>Kamrul-Hasan ABM, Pappachan JM, Ashraf H, Nagendra L, Dutta D, Kuchay MS, Shaikh S. Safety and efficacy of glucagon-like peptide-1 receptor agonists in individuals with type 2 diabetes mellitus fasting during Ramadan: a systematic review and meta-analysis. <i>World J Methodol</i> 2025; 15(4): 105478</p> |
| URL |
https://www.wjgnet.com/2222-0682/full/v15/i4/105478.htm |
| DOI |
https://dx.doi.org/10.5662/wjm.v15.i4.105478 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
